HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 614 filers reported holding HORIZON THERAPEUTICS PUB L in Q1 2022. The put-call ratio across all filers is 0.63 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $770,127,853 | +8.2% | 6,656,823 | -3.8% | 3.86% | +4.4% |
| Q2 2023 | $711,909,496 | +20.4% | 6,921,823 | +27.7% | 3.70% | +13.0% |
| Q1 2023 | $591,519,482 | +40.7% | 5,419,823 | +46.7% | 3.27% | +30.4% |
| Q4 2022 | $420,482,237 | +281.6% | 3,694,923 | +107.6% | 2.51% | +312.2% |
| Q3 2022 | $110,178,000 | – | 1,780,223 | +62.9% | 0.61% | – |
| Q2 2022 | $0 | -100.0% | 1,093,160 | -26.2% | 0.00% | -100.0% |
| Q1 2022 | $155,750,000 | +3.5% | 1,480,377 | +6.0% | 0.75% | +0.1% |
| Q4 2021 | $150,456,000 | +17.2% | 1,396,217 | +19.1% | 0.75% | +25.4% |
| Q3 2021 | $128,400,000 | +174.2% | 1,172,174 | +134.4% | 0.60% | +213.6% |
| Q2 2021 | $46,820,000 | +301.8% | 500,000 | +233.3% | 0.19% | +135.8% |
| Q3 2020 | $11,652,000 | – | 150,000 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |